Bednarczyk J L, Szabo M C, Wygant J N, Lazarovits A I, McIntyre B W
Department of Immunology, University of Texas M. D. Anderson Cancer Center, Houston 77030.
J Biol Chem. 1994 Mar 18;269(11):8348-54.
The alpha 4 integrin subunit can associate with either the beta 1- or beta 7-integrin subunit to form two unique adhesion receptors alpha 4 beta 1 and alpha 4 beta 7. We developed a monoclonal antibody (mAb 19H8) that immunoprecipitated alpha 4 beta 1, induced homotypic leukocyte aggregation, and blocked the binding of cells to a synthetic peptide corresponding to the CS-1 peptide region of fibronectin. Aggregation cross-blocking analysis suggested that mAb 19H8 belonged to the group of mAbs that react with the B2 epitope of the alpha 4 subunit (alpha 4.B2 epitope); however, unlike the alpha 4.B2-specific mAb L25, mAb 19H8 did not immunoprecipitate alpha 4 beta 7. In addition, mAb 19H8 did not bind to beta 1-positive cells unless transfected with alpha 4 cDNA. These results indicated that mAb 19H8 was not specific for an individual alpha 4, beta 1, or beta 7 subunit but reacted with an epitope formed from the association of alpha 4 with beta 1. Separating the alpha 4 from the beta 1 subunit, by removing divalent cations or by treatment with high pH, disrupted mAb 19H8 binding. In contrast, the alpha 4-specific mAb L25 and the beta 1-specific mAb 18D3 could react with their respective subunits without subunit association. Therefore, mAb 19H8 defined a novel regulatory epitope expressed by the integrin alpha 4 beta 1.
α4整合素亚基可与β1或β7整合素亚基结合,形成两种独特的黏附受体α4β1和α4β7。我们研制了一种单克隆抗体(mAb 19H8),它能免疫沉淀α4β1,诱导同型白细胞聚集,并阻断细胞与对应于纤连蛋白CS-1肽段区域的合成肽的结合。聚集交叉阻断分析表明,mAb 19H8属于与α4亚基的B2表位(α4.B2表位)反应的单克隆抗体组;然而,与α4.B2特异性单克隆抗体L25不同,mAb 19H8不能免疫沉淀α4β7。此外,mAb 19H8除非转染α4 cDNA,否则不与β1阳性细胞结合。这些结果表明,mAb 19H8并非对单个α4、β1或β7亚基具有特异性,而是与由α4与β1结合形成的表位发生反应。通过去除二价阳离子或用高pH处理将α4与β1亚基分离,会破坏mAb 19H8的结合。相反,α4特异性单克隆抗体L25和β1特异性单克隆抗体18D3可在无亚基结合的情况下与其各自的亚基发生反应。因此,mAb 19H8定义了一种由整合素α4β1表达的新型调节表位。